▶ 調査レポート

マルチプレックス免疫蛍光測定法のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Multiplex Immunofluorescence Assay Market Insights and Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。マルチプレックス免疫蛍光測定法のグローバル市場インサイト・予測(~2028年) / Global Multiplex Immunofluorescence Assay Market Insights and Forecast to 2028 / QY2203B06475資料のイメージです。• レポートコード:QY2203B06475
• 出版社/出版日:QYResearch / 2022年3月25日
• レポート形態:英文、PDF、79ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のマルチプレックス免疫蛍光測定法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にマルチプレックス免疫蛍光測定法の世界市場のxxx%を占める「材料」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「学術研究機関」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のマルチプレックス免疫蛍光測定法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのマルチプレックス免疫蛍光測定法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのマルチプレックス免疫蛍光測定法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

マルチプレックス免疫蛍光測定法のグローバル主要メーカーには、Fluidigm、Akoya Biosciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

マルチプレックス免疫蛍光測定法市場は、種類と用途によって区分されます。世界のマルチプレックス免疫蛍光測定法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
材料、機器、ソフトウエア、サービス

【用途別セグメント】
学術研究機関、病院、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- マルチプレックス免疫蛍光測定法製品概要
- 種類別市場(材料、機器、ソフトウエア、サービス)
- 用途別市場(学術研究機関、病院、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のマルチプレックス免疫蛍光測定法販売量予測2017-2028
- 世界のマルチプレックス免疫蛍光測定法売上予測2017-2028
- マルチプレックス免疫蛍光測定法の地域別販売量
- マルチプレックス免疫蛍光測定法の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別マルチプレックス免疫蛍光測定法販売量
- 主要メーカー別マルチプレックス免疫蛍光測定法売上
- 主要メーカー別マルチプレックス免疫蛍光測定法価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(材料、機器、ソフトウエア、サービス)
- マルチプレックス免疫蛍光測定法の種類別販売量
- マルチプレックス免疫蛍光測定法の種類別売上
- マルチプレックス免疫蛍光測定法の種類別価格
・用途別市場規模(学術研究機関、病院、その他)
- マルチプレックス免疫蛍光測定法の用途別販売量
- マルチプレックス免疫蛍光測定法の用途別売上
- マルチプレックス免疫蛍光測定法の用途別価格
・北米市場
- 北米のマルチプレックス免疫蛍光測定法市場規模(種類別、用途別)
- 主要国別のマルチプレックス免疫蛍光測定法市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのマルチプレックス免疫蛍光測定法市場規模(種類別、用途別)
- 主要国別のマルチプレックス免疫蛍光測定法市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のマルチプレックス免疫蛍光測定法市場規模(種類別、用途別)
- 主要国別のマルチプレックス免疫蛍光測定法市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のマルチプレックス免疫蛍光測定法市場規模(種類別、用途別)
- 主要国別のマルチプレックス免疫蛍光測定法市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのマルチプレックス免疫蛍光測定法市場規模(種類別、用途別)
- 主要国別のマルチプレックス免疫蛍光測定法市場規模(トルコ、サウジアラビア)
・企業情報
Fluidigm、Akoya Biosciences
・産業チェーン及び販売チャネル分析
- マルチプレックス免疫蛍光測定法の産業チェーン分析
- マルチプレックス免疫蛍光測定法の原材料
- マルチプレックス免疫蛍光測定法の生産プロセス
- マルチプレックス免疫蛍光測定法の販売及びマーケティング
- マルチプレックス免疫蛍光測定法の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- マルチプレックス免疫蛍光測定法の産業動向
- マルチプレックス免疫蛍光測定法のマーケットドライバー
- マルチプレックス免疫蛍光測定法の課題
- マルチプレックス免疫蛍光測定法の阻害要因
・主な調査結果

Market Analysis and Insights: Global Multiplex Immunofluorescence Assay Market
The global Multiplex Immunofluorescence Assay market size is projected to reach US$ 2309.6 million by 2028, from US$ 1657 million in 2021, at a CAGR of 4.8% during 2022-2028.
Global key players of multiplex immunofluorescence assay include Fluidigm, Akoya Biosciences. North America is the largest market, with a share about 35%, followed by Asia Pacific and Europe with the share about 30% and 25%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiplex Immunofluorescence Assay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiplex Immunofluorescence Assay market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiplex Immunofluorescence Assay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiplex Immunofluorescence Assay market.
Global Multiplex Immunofluorescence Assay Scope and Market Size
Multiplex Immunofluorescence Assay market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Multiplex Immunofluorescence Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Material
Equipment
Software and Service
Segment by Application
Academic and Research Institution
Hospital
Others
By Company
Fluidigm
Akoya Biosciences
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Immunofluorescence Assay Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Material
1.2.3 Equipment
1.2.4 Software and Service
1.3 Market by Application
1.3.1 Global Multiplex Immunofluorescence Assay Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Academic and Research Institution
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Immunofluorescence Assay Market Perspective (2017-2028)
2.2 Multiplex Immunofluorescence Assay Growth Trends by Region
2.2.1 Multiplex Immunofluorescence Assay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Multiplex Immunofluorescence Assay Historic Market Size by Region (2017-2022)
2.2.3 Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2023-2028)
2.3 Multiplex Immunofluorescence Assay Market Dynamics
2.3.1 Multiplex Immunofluorescence Assay Industry Trends
2.3.2 Multiplex Immunofluorescence Assay Market Drivers
2.3.3 Multiplex Immunofluorescence Assay Market Challenges
2.3.4 Multiplex Immunofluorescence Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue
3.1.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue (2017-2022)
3.1.2 Global Multiplex Immunofluorescence Assay Revenue Market Share by Players (2017-2022)
3.2 Global Multiplex Immunofluorescence Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex Immunofluorescence Assay Revenue
3.4 Global Multiplex Immunofluorescence Assay Market Concentration Ratio
3.4.1 Global Multiplex Immunofluorescence Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Immunofluorescence Assay Revenue in 2021
3.5 Multiplex Immunofluorescence Assay Key Players Head office and Area Served
3.6 Key Players Multiplex Immunofluorescence Assay Product Solution and Service
3.7 Date of Enter into Multiplex Immunofluorescence Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Immunofluorescence Assay Breakdown Data by Type
4.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Type (2017-2022)
4.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2023-2028)
5 Multiplex Immunofluorescence Assay Breakdown Data by Application
5.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Application (2017-2022)
5.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Multiplex Immunofluorescence Assay Market Size (2017-2028)
6.2 North America Multiplex Immunofluorescence Assay Market Size by Type
6.2.1 North America Multiplex Immunofluorescence Assay Market Size by Type (2017-2022)
6.2.2 North America Multiplex Immunofluorescence Assay Market Size by Type (2023-2028)
6.2.3 North America Multiplex Immunofluorescence Assay Market Share by Type (2017-2028)
6.3 North America Multiplex Immunofluorescence Assay Market Size by Application
6.3.1 North America Multiplex Immunofluorescence Assay Market Size by Application (2017-2022)
6.3.2 North America Multiplex Immunofluorescence Assay Market Size by Application (2023-2028)
6.3.3 North America Multiplex Immunofluorescence Assay Market Share by Application (2017-2028)
6.4 North America Multiplex Immunofluorescence Assay Market Size by Country
6.4.1 North America Multiplex Immunofluorescence Assay Market Size by Country (2017-2022)
6.4.2 North America Multiplex Immunofluorescence Assay Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Multiplex Immunofluorescence Assay Market Size (2017-2028)
7.2 Europe Multiplex Immunofluorescence Assay Market Size by Type
7.2.1 Europe Multiplex Immunofluorescence Assay Market Size by Type (2017-2022)
7.2.2 Europe Multiplex Immunofluorescence Assay Market Size by Type (2023-2028)
7.2.3 Europe Multiplex Immunofluorescence Assay Market Share by Type (2017-2028)
7.3 Europe Multiplex Immunofluorescence Assay Market Size by Application
7.3.1 Europe Multiplex Immunofluorescence Assay Market Size by Application (2017-2022)
7.3.2 Europe Multiplex Immunofluorescence Assay Market Size by Application (2023-2028)
7.3.3 Europe Multiplex Immunofluorescence Assay Market Share by Application (2017-2028)
7.4 Europe Multiplex Immunofluorescence Assay Market Size by Country
7.4.1 Europe Multiplex Immunofluorescence Assay Market Size by Country (2017-2022)
7.4.2 Europe Multiplex Immunofluorescence Assay Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size (2017-2028)
8.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Type
8.2.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Share by Type (2017-2028)
8.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Application
8.3.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Share by Application (2017-2028)
8.4 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Region
8.4.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Multiplex Immunofluorescence Assay Market Size (2017-2028)
9.2 Latin America Multiplex Immunofluorescence Assay Market Size by Type
9.2.1 Latin America Multiplex Immunofluorescence Assay Market Size by Type (2017-2022)
9.2.2 Latin America Multiplex Immunofluorescence Assay Market Size by Type (2023-2028)
9.2.3 Latin America Multiplex Immunofluorescence Assay Market Share by Type (2017-2028)
9.3 Latin America Multiplex Immunofluorescence Assay Market Size by Application
9.3.1 Latin America Multiplex Immunofluorescence Assay Market Size by Application (2017-2022)
9.3.2 Latin America Multiplex Immunofluorescence Assay Market Size by Application (2023-2028)
9.3.3 Latin America Multiplex Immunofluorescence Assay Market Share by Application (2017-2028)
9.4 Latin America Multiplex Immunofluorescence Assay Market Size by Country
9.4.1 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2017-2022)
9.4.2 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size (2017-2028)
10.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Type
10.2.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Share by Type (2017-2028)
10.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Application
10.3.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Share by Application (2017-2028)
10.4 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country
10.4.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fluidigm
11.1.1 Fluidigm Company Details
11.1.2 Fluidigm Business Overview
11.1.3 Fluidigm Multiplex Immunofluorescence Assay Introduction
11.1.4 Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2017-2022)
11.1.5 Fluidigm Recent Developments
11.2 Akoya Biosciences
11.2.1 Akoya Biosciences Company Details
11.2.2 Akoya Biosciences Business Overview
11.2.3 Akoya Biosciences Multiplex Immunofluorescence Assay Introduction
11.2.4 Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2017-2022)
11.2.5 Akoya Biosciences Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Multiplex Immunofluorescence Assay Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Material
Table 3. Key Players of Equipment
Table 4. Key Players of Software and Service
Table 5. Global Multiplex Immunofluorescence Assay Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Multiplex Immunofluorescence Assay Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Multiplex Immunofluorescence Assay Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Multiplex Immunofluorescence Assay Market Share by Region (2017-2022)
Table 9. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Multiplex Immunofluorescence Assay Market Share by Region (2023-2028)
Table 11. Multiplex Immunofluorescence Assay Market Trends
Table 12. Multiplex Immunofluorescence Assay Market Drivers
Table 13. Multiplex Immunofluorescence Assay Market Challenges
Table 14. Multiplex Immunofluorescence Assay Market Restraints
Table 15. Global Multiplex Immunofluorescence Assay Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Multiplex Immunofluorescence Assay Revenue Share by Players (2017-2022)
Table 17. Global Top Multiplex Immunofluorescence Assay by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Immunofluorescence Assay as of 2021)
Table 18. Ranking of Global Top Multiplex Immunofluorescence Assay Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Multiplex Immunofluorescence Assay Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Multiplex Immunofluorescence Assay Product Solution and Service
Table 22. Date of Enter into Multiplex Immunofluorescence Assay Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Multiplex Immunofluorescence Assay Revenue Market Share by Type (2017-2022)
Table 26. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Multiplex Immunofluorescence Assay Revenue Market Share by Type (2023-2028)
Table 28. Global Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Multiplex Immunofluorescence Assay Revenue Share by Application (2017-2022)
Table 30. Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Multiplex Immunofluorescence Assay Revenue Share by Application (2023-2028)
Table 32. North America Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Multiplex Immunofluorescence Assay Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Multiplex Immunofluorescence Assay Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Multiplex Immunofluorescence Assay Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Multiplex Immunofluorescence Assay Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Multiplex Immunofluorescence Assay Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Multiplex Immunofluorescence Assay Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Multiplex Immunofluorescence Assay Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Multiplex Immunofluorescence Assay Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Multiplex Immunofluorescence Assay Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Multiplex Immunofluorescence Assay Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Multiplex Immunofluorescence Assay Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Multiplex Immunofluorescence Assay Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Multiplex Immunofluorescence Assay Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Multiplex Immunofluorescence Assay Market Size by Country (2023-2028) & (US$ Million)
Table 62. Fluidigm Company Details
Table 63. Fluidigm Business Overview
Table 64. Fluidigm Multiplex Immunofluorescence Assay Product
Table 65. Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) & (US$ Million)
Table 66. Fluidigm Recent Developments
Table 67. Akoya Biosciences Company Details
Table 68. Akoya Biosciences Business Overview
Table 69. Akoya Biosciences Multiplex Immunofluorescence Assay Product
Table 70. Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2017-2022) & (US$ Million)
Table 71. Akoya Biosciences Recent Developments
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplex Immunofluorescence Assay Market Share by Type: 2021 VS 2028
Figure 2. Material Features
Figure 3. Equipment Features
Figure 4. Software and Service Features
Figure 5. Global Multiplex Immunofluorescence Assay Market Share by Application: 2021 VS 2028
Figure 6. Academic and Research Institution Case Studies
Figure 7. Hospital Case Studies
Figure 8. Others Case Studies
Figure 9. Multiplex Immunofluorescence Assay Report Years Considered
Figure 10. Global Multiplex Immunofluorescence Assay Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Multiplex Immunofluorescence Assay Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Multiplex Immunofluorescence Assay Market Share by Region: 2021 VS 2028
Figure 13. Global Multiplex Immunofluorescence Assay Market Share by Players in 2021
Figure 14. Global Top Multiplex Immunofluorescence Assay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Immunofluorescence Assay as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Multiplex Immunofluorescence Assay Revenue in 2021
Figure 16. North America Multiplex Immunofluorescence Assay Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Multiplex Immunofluorescence Assay Market Size Market Share by Type (2017-2028)
Figure 18. North America Multiplex Immunofluorescence Assay Market Size Market Share by Application (2017-2028)
Figure 19. North America Multiplex Immunofluorescence Assay Market Size Share by Country (2017-2028)
Figure 20. United States Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Multiplex Immunofluorescence Assay Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Multiplex Immunofluorescence Assay Market Size Market Share by Type (2017-2028)
Figure 24. Europe Multiplex Immunofluorescence Assay Market Size Market Share by Application (2017-2028)
Figure 25. Europe Multiplex Immunofluorescence Assay Market Size Share by Country (2017-2028)
Figure 26. Germany Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Multiplex Immunofluorescence Assay Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Multiplex Immunofluorescence Assay Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Multiplex Immunofluorescence Assay Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Multiplex Immunofluorescence Assay Market Size Share by Region (2017-2028)
Figure 36. China Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Multiplex Immunofluorescence Assay Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Multiplex Immunofluorescence Assay Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Multiplex Immunofluorescence Assay Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Multiplex Immunofluorescence Assay Market Size Share by Country (2017-2028)
Figure 46. Mexico Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Multiplex Immunofluorescence Assay Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Multiplex Immunofluorescence Assay Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Multiplex Immunofluorescence Assay Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Multiplex Immunofluorescence Assay Market Size Share by Country (2017-2028)
Figure 52. Turkey Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Multiplex Immunofluorescence Assay Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Fluidigm Revenue Growth Rate in Multiplex Immunofluorescence Assay Business (2017-2022)
Figure 56. Akoya Biosciences Revenue Growth Rate in Multiplex Immunofluorescence Assay Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed